- Home
- JAGX vs GITS Comparison
JAGX vs GITS Comparison
Compare JAGX & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- GITS
- Stock Information
- Founded
- JAGX 2013
- GITS 2018
- Country
- JAGX United States
- GITS South Korea
- Employees
- JAGX N/A
- GITS N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- GITS
- Sector
- JAGX Health Care
- GITS
- Exchange
- JAGX Nasdaq
- GITS Nasdaq
- Market Cap
- JAGX 3.5M
- GITS 4.1M
- IPO Year
- JAGX N/A
- GITS N/A
- Fundamental
- Price
- JAGX $2.70
- GITS $2.83
- Analyst Decision
- JAGX Strong Buy
- GITS
- Analyst Count
- JAGX 1
- GITS 0
- Target Price
- JAGX $60.00
- GITS N/A
- AVG Volume (30 Days)
- JAGX 86.0K
- GITS 2.4M
- Earning Date
- JAGX 08-12-2025
- GITS 07-22-2025
- Dividend Yield
- JAGX N/A
- GITS N/A
- EPS Growth
- JAGX N/A
- GITS N/A
- EPS
- JAGX N/A
- GITS N/A
- Revenue
- JAGX $11,552,000.00
- GITS N/A
- Revenue This Year
- JAGX $22.41
- GITS N/A
- Revenue Next Year
- JAGX $30.00
- GITS N/A
- P/E Ratio
- JAGX N/A
- GITS N/A
- Revenue Growth
- JAGX 13.93
- GITS N/A
- 52 Week Low
- JAGX $2.43
- GITS $0.87
- 52 Week High
- JAGX $110.75
- GITS $9.78
- Technical
- Relative Strength Index (RSI)
- JAGX 33.71
- GITS N/A
- Support Level
- JAGX $2.53
- GITS N/A
- Resistance Level
- JAGX $2.65
- GITS N/A
- Average True Range (ATR)
- JAGX 0.18
- GITS 0.00
- MACD
- JAGX 0.14
- GITS 0.00
- Stochastic Oscillator
- JAGX 31.03
- GITS 0.00
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.